Research | Published:

Guiding the Selection of Human Antibodies from Phage Display Repertoires to a Single Epitope of an Antigen

Bio/Technology volume 12, pages 899903 (1994) | Download Citation

Subjects

Abstract

We have developed a strategy for guiding the selection of human antibody fragments from phage display repertoires to a single epitope of an antigen, using rodent monoclonal antibodies as a template. Thus the heavy chain of a rodent antibody (MAb32) directed against human tumor necrosis factor α (TNFα) was cloned and paired as a template chain with a repertoire of human light chains for display as Fab fragments on filamentous phage. The phage were selected by binding to the antigen. The selected human light chains were in turn paired with a repertoire of human heavy chains displayed on phage, and the phage selected again. The isolated phage displaying human antibody fragments binding to TNFα also bound to a peptide comprising the N–terminal region of TNFα as with MAb32. One of the human Fab fragments was recloned for expression as a glycosylated human antibody in mammalian cells: Binding to TNFα could be competed with MAb32 or with anti–serum to the peptide, indicating the same epitope. The human antibody was found to have a binding affinity (Kd=15 nM) similar to MAb32 (Kd=26 nM). The process contrasts with existing means of “humanizing” rodent monoclonal antibodies in that the antibodies derived are completely human.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , and 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348: 552–554.

  2. 2.

    , , and 1994. Making antibodies by phage display technology. Ann. Rev. Immunol. 12: 433–455.

  3. 3.

    , , and 1991. Making antibody fragments using phage display libraries. Nature 352: 624–628.

  4. 4.

    , et al. 1994. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. In press.

  5. 5.

    , , , , and 1992. By-passing immunization: Building high affinity human antibodies by chain shuffling. Bio/Technology 10: 779–783.

  6. 6.

    , and 1993. High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site. Proc. Natl. Acad. Sci. USA 90: 10003–10007.

  7. 7.

    , , , , and 1991. By-passing immunization: Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222: 581–597.

  8. 8.

    and 1992. By-passing immunisation. Human antibodies from synthetic repertoires of germline VH-gene segments rearranged in vitro. J. Mol. Biol 227: 381–388.

  9. 9.

    , , , , , , , , , , and 1993. Human anti-self antibodies with high specificity from phage display libraries. EMBO J. 12: 725–734.

  10. 10.

    , , , , and 1991. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic individuals. Proc. Natl. Acad. Sci. USA 88: 10134–10137.

  11. 11.

    , , , , , , , , , and 1992. Human combinatorial antibody libraries to hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 89: 3175–3179.

  12. 12.

    , , , , , , , and 1993. Human antibody fragments specific for human blood group antigens from a phage display library. Bio/Technology 11: 1145–1149.

  13. 13.

    , , , , , and 1994. Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents. EMBO J. 13: 692–698.

  14. 14.

    , , and 1994. In vitro assembly of repertoires of antibody chains by renaturation on the surface of phage. J. Mol. Biol. 239: 68–78.

  15. 15.

    , , , , and 1991. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucl. Acids Res. 19: 4133–4137.

  16. 16.

    and 1993. Cloning and sequencing of human immunoglobulin V lambda gene segments. Eur. J. Immunol. 23: 1456–1461.

  17. 17.

    , , , and 1992. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J. Mol. Biol. 227: 776–798.

  18. 18.

    and 1993. Selective enhancement of tumour necrosis factor activity: mapping regions with monoclonal antibodies. Biomed. Chem. Lett. 3: 457–462.

  19. 19.

    , , and 1991. Antigenic structure of human tumour necrosis factor: recognition of distinct regions of TNF alpha by different tumour cell receptors. Mol. Immunol. 28: 79–86.

  20. 20.

    , , and 1985. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods 77: 305–319.

  21. 21.

    and 1993. Methods for measurement of antibody/antigen affinity based on ELISA and RIA. Curr. Opin. Immunol. 5: 278–81.

  22. 22.

    , and 1994. A directory of human germ-line Vκ segments reveals a strong bias in their usage. Eur. J. Immunol. 24: 827–836.

  23. 23.

    , , and 1993. Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires. Nucl. Acids Res. 21: 2265–2266.

  24. 24.

    , , , , , , and 1989. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 246: 1275–1281.

  25. 25.

    and 1993. Humanized antibodies. Trends Pharmacol. Sci. 14: 139–143.

  26. 26.

    , , , and 1986. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321: 522–525.

  27. 27.

    , , , and 1991. Sequences of Proteins of Immunological Interest. 5th Edit. U.S. Department of Health and Human Services, Public Health Service National Institutes of Health.

  28. 28.

    , , and 1989. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86: 3833–3837.

  29. 29.

    and 1992. Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol. 224: 487–499.

  30. 30.

    , and 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463–5467.

Download references

Author information

Author notes

    • Hennie R. Hoogenboom

    Corresponding author.

Affiliations

  1. MRC Centre for Protein Engineering, MRC Centre, Hills Road, Cambridge CB2 2QH, U.K.

    • Laurent S. Jespers
    • , Greg Winter
    •  & Hennie R. Hoogenboom
  2. Cambridge Antibody Technology Ltd., The Science Park, Melbourn, Cambridgeshire SG8 6EJ, U.K. Present address. (L.S.J.) Corvas International N.V., Jozef Plateaustraat 22, B-9000 Gent, Belgium

    • Andy Roberts
    • , Stephen M. Mahler
    •  & Hennie R. Hoogenboom
  3. (S.M.M.) University of New South Wales, P.O. Box 1, Kensington, NSW, Australia.

    • Laurent S. Jespers
    • , Andy Roberts
    • , Stephen M. Mahler
    • , Greg Winter
    •  & Hennie R. Hoogenboom

Authors

  1. Search for Laurent S. Jespers in:

  2. Search for Andy Roberts in:

  3. Search for Stephen M. Mahler in:

  4. Search for Greg Winter in:

  5. Search for Hennie R. Hoogenboom in:

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nbt0994-899

Further reading